<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00217087</url>
  </required_header>
  <id_info>
    <org_study_id>1399-05</org_study_id>
    <secondary_id>R01CA111603</secondary_id>
    <nct_id>NCT00217087</nct_id>
  </id_info>
  <brief_title>Endoscopic Therapy of Early Cancer in Barretts Esophagus</brief_title>
  <official_title>Endoscopic Therapy of Early Cancer in Barretts Esophagus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to see if treatment for esophageal cancer can be done using
      endoscopy for patients ineligible for surgical or radiological therapy. The standard method
      of treating this type of cancer is surgical removal of the esophagus. The study will
      determine if removing just the cancer with endoscopy is enough treatment or if the addition
      of another treatment called photodynamic therapy (treatment with a red light and a drug
      called sodium porfimer) is needed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participant visit requirements: Screening visit which will last 1 - 2 days, if assigned to
      photodynamic therapy, there will be a 3 day visit for treatment. Participants must return for
      a 1 day visit every three months for one year.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of Dysplasia on Histology at 12 Months</measure>
    <time_frame>12 months post therapy</time_frame>
    <description>All specimens were reviewed by two expert GI pathologists for presence of and/or level of dysplasia in Barrett's Esophagus</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fluorescence In Situ Hybridization (FISH) Markers at 12 Months.</measure>
    <time_frame>12 months post therapy</time_frame>
    <description>Whether or not positive fish markers measured by polysomy were associated with outcomes.
Markers in this study include: 9q21 /017q (her2) / 8q24/ 20q / CEP17 / 17p. Polysomy and Trisomy were documented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>end of study</time_frame>
    <description>Quality of life in both groups (EMR and EMR with photodynamic therapy) SF36</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Early Stage Esophageal Adenocarcinoma</condition>
  <condition>Barrett Esophagus</condition>
  <arm_group>
    <arm_group_label>Endoscopic Mucosal Resection</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will undergo endoscopic mucosal resection at time of endoscopy if indicated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Photodynamic Therapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will have endoscopic mucosal resection with photodynamic therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic Mucosal Resection</intervention_name>
    <description>Endoscopic mucosal resection at time of endoscopy if indicated.</description>
    <arm_group_label>Endoscopic Mucosal Resection</arm_group_label>
    <arm_group_label>Photodynamic Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Photodynamic Therapy</intervention_name>
    <description>Porfimer sodium 2mg/kg</description>
    <arm_group_label>Photodynamic Therapy</arm_group_label>
    <other_name>Photofrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-recurrent adenocarcinoma in Barrett's Esophagus confirmed by two experienced
             gastrointestinal pathologists

          -  No evidence of submucosal invasion

          -  No evidence of metastatic disease in either regional or distal lymph nodes, or other
             organs

          -  Pre-entry CT scans of the upper abdomen and chest and Endoscopic Ultrasound (EUS) of
             the tumor and regional lymph nodes are required. Fusion PET scans are suggested for
             any indeterminate lesions

          -  Zubrod Performance Status 0-1

          -  Participants must be have oral intake of greater than 1700 calories a day

          -  Patient must not have had a second malignancy, other than curable non-melanoma skin
             cancer or cervical cancer in situ, unless disease free for greater than or equal to 3
             years and deemed cured by their hematologist and/or oncologist

          -  Staging procedures should be performed prior to study entry

          -  All patients or legally authorized representative must sign a study-specific informed
             consent prior to randomization.

        Exclusion criteria:

          -  Prior major esophageal surgery

          -  Patients who are unable to tolerate endoscopic procedures

          -  Due to the possible toxic effects of photodynamic therapy and endoscopic sedation to
             embryos, pregnant or lactating women or men unable or unwilling to practice
             contraception are excluded

          -  Patients with an uncontrolled diabetes, heart disease, or hypertension

          -  Patient and/or legally authorized representative who are unable to comprehend the
             study requirements or who are not likely to comply with the study parameters.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth K. Wang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <results_first_submitted>March 2, 2015</results_first_submitted>
  <results_first_submitted_qc>August 26, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 25, 2015</results_first_posted>
  <last_update_submitted>November 23, 2015</last_update_submitted>
  <last_update_submitted_qc>November 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kenneth K. Wang</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited from December 1, 2005 thru April 26, 2011 at Mayo Clinic in Rochester, Minnesota.</recruitment_details>
      <pre_assignment_details>We intended to recruit 100 patients with early cancer and were able to recruit a total of 124 patients in this single center randomized trial. A total of 73 patients could actually be randomized due to inability to completely remove the cancer, finding evidence of high risk of metastasis, or refusing randomization to photodynamic therapy.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Endoscopic Mucosal Resection</title>
          <description>Patients will undergo endoscopic mucosal resection at time of endoscopy if indicated.</description>
        </group>
        <group group_id="P2">
          <title>Photodynamic Therapy</title>
          <description>Patients will have endoscopic mucosal resection (if indicated at time of endoscopy) followed by photodynamic therapy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>decided to have esophagectomy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>completed less than 12 months return</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Endoscopic Mucosl Resection</title>
          <description>patients will undergo endoscopic mucosal resection at time of endoscopy if indicated</description>
        </group>
        <group group_id="B2">
          <title>Photodynamic Therapy</title>
          <description>patients will have endoscopic mucosal resection (if indicated at time of endoscopy) followed by photodynamic therapy.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="73"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Level of Dysplasia on Histology at 12 Months</title>
        <description>All specimens were reviewed by two expert GI pathologists for presence of and/or level of dysplasia in Barrett's Esophagus</description>
        <time_frame>12 months post therapy</time_frame>
        <population>4 participants in the photodynamic therapy group completed at least 3 but less than 12 months follow up post therapy, so they were not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Endoscopic Mucosal Resection</title>
            <description>Patients will undergo endoscopic mucosal resection at time of endoscopy if indicated.</description>
          </group>
          <group group_id="O2">
            <title>Photodynamic Therapy</title>
            <description>Patients will have endoscopic mucosal resection (if indicated at time of endoscopy) followed by photodynamic therapy.</description>
          </group>
        </group_list>
        <measure>
          <title>Level of Dysplasia on Histology at 12 Months</title>
          <description>All specimens were reviewed by two expert GI pathologists for presence of and/or level of dysplasia in Barrett's Esophagus</description>
          <population>4 participants in the photodynamic therapy group completed at least 3 but less than 12 months follow up post therapy, so they were not included in this analysis.</population>
          <units>paricipants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Decreases in dysplasia from enrollment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No improvement or worsened level of dysplasia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0098</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fluorescence In Situ Hybridization (FISH) Markers at 12 Months.</title>
        <description>Whether or not positive fish markers measured by polysomy were associated with outcomes.
Markers in this study include: 9q21 /017q (her2) / 8q24/ 20q / CEP17 / 17p. Polysomy and Trisomy were documented.</description>
        <time_frame>12 months post therapy</time_frame>
        <population>4 participants in the PDT group completed at least 3 months of follow up but not 12 months</population>
        <group_list>
          <group group_id="O1">
            <title>Endoscopic Mucosal Resection FISH Polysomy Negative</title>
            <description>FISH cytology results prior to therapy were negative</description>
          </group>
          <group group_id="O2">
            <title>Endoscopic Mucosal Resection FISH Positive Positive</title>
            <description>FISH cytology results were positive prior to therapy</description>
          </group>
          <group group_id="O3">
            <title>Photodynamic Therapy FISH POSITIVE</title>
            <description>FISH cytology results were positive prior to therapy</description>
          </group>
          <group group_id="O4">
            <title>Photodynamic Therapy FISH NEGATIVE</title>
            <description>FISH cytology results prior to therapy were negative</description>
          </group>
        </group_list>
        <measure>
          <title>Fluorescence In Situ Hybridization (FISH) Markers at 12 Months.</title>
          <description>Whether or not positive fish markers measured by polysomy were associated with outcomes.
Markers in this study include: 9q21 /017q (her2) / 8q24/ 20q / CEP17 / 17p. Polysomy and Trisomy were documented.</description>
          <population>4 participants in the PDT group completed at least 3 months of follow up but not 12 months</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Decrease level of dysplasia post therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>no change or worsening of dysplasia post therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.34</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Quality of Life</title>
        <description>Quality of life in both groups (EMR and EMR with photodynamic therapy) SF36</description>
        <time_frame>end of study</time_frame>
        <population>25 patients did not return completed SF36 at 12 month of follow up their results were not used in final analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Endoscopic Mucosal Resection</title>
            <description>Patients will undergo EMR at time of endoscopy if indicated.</description>
          </group>
          <group group_id="O2">
            <title>Endoscopic Mucosal Resection and Photodynamic Therapy</title>
            <description>Patients will have EMR (if indicated at time of endoscopy) followed by photodynamic therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quality of Life</title>
          <description>Quality of life in both groups (EMR and EMR with photodynamic therapy) SF36</description>
          <population>25 patients did not return completed SF36 at 12 month of follow up their results were not used in final analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>qaulity of life remained the same of improved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>decrease in qualify of life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2</p_value>
            <method>Chi-squared</method>
            <method_desc>the only participant who reported a decrease quality of life related that to a recent surgery not their esophagus.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 years, 2 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Endoscopic Mucosl Resection</title>
          <description>patients will undergo endoscopic mucosal resection at time of endoscopy if indicated</description>
        </group>
        <group group_id="E2">
          <title>Photodynamic Therapy</title>
          <description>patients will have endoscopic mucosal resection (if indicated at time of endoscopy) followed by photodynamic therapy.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>heart attack resulting in death</sub_title>
                <description>not related to study participation</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure - Sepsis</sub_title>
                <description>unrelated to study participation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respitory Failure / Sepsis</sub_title>
                <description>unrelated to study participation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrilation</sub_title>
                <description>not related to study participation</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <description>known/anticipated risk - post endoscopic mucosal resection - treated endoscopically or observation only</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="37"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <description>Participant had pain last longer than is anticipated after photodynamic therapy, treated with medication</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="37"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <description>known and anticipated event post photodynamic therapy</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <description>required hospitalization with IV fluids both incidents were unrelated to study participation</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Photosensitivity</sub_title>
                <description>known and anticipated risk of Photodynamic therapy (Photofrin)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kenneth Wang MD</name_or_title>
      <organization>Mayo Clinic</organization>
      <phone>507-255-7495</phone>
      <email>wang.kenneth@mayo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

